Concordant Regulation of Gene Expression by Hypoxia and 2-Oxoglutarate-dependent Dioxygenase Inhibition
Open accessThe DOI matches its Crossref record; 58 of the 58 references it cites were found in a registry or an index.
Abstract
Studies of gene regulation by oxygen have revealed novel signal pathways that regulate the hypoxia-inducible factor (HIF) transcriptional system through post-translational hydroxylation of specific prolyl and asparaginyl residues in HIF-alpha subunits. These oxygen-sensitive modifications are catalyzed by members of the 2-oxoglutarate (2-OG) dioxygenase family (PHD1, PHD2, PHD3, and FIH-1), raising an important question regarding the extent of involvement of these and other enzymes of the same family in directing the global changes in gene expression that are induced by hypoxia. To address this, we compared patterns of gene expression induced by hypoxia and by a nonspecific 2-OG-dependent dioxygenase inhibitor, dimethyloxalylglycine (DMOG), among a set of 22,000 transcripts, by microarray analysis of MCF7 cells. By using short interfering RNA-based suppression of HIF-alpha subunits, we also compared responses that were dependent on, or independent of, the HIF system. Results revealed striking concordance between patterns of gene expression induced by hypoxia and by DMOG, indicating the central involvement of 2-OG-dependent dioxygenases in oxygen-regulated gene expression. Many of these responses were suppressed by short interfering RNAs directed against HIF-1alpha and HIF-2alpha, with HIF-1alpha suppression manifesting substantially greater effects than HIF-2alpha suppression, supporting the importance of HIF pathways. Nevertheless, the definition of genes regulated by both hypoxia and DMOG, but not HIF, distinguished other pathways most likely involving the action of 2-OG-dependent dioxygenases on non-HIF substrates.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“HIF-1 is a transcription factor that regulates the expression of hundreds of genes in response to hypoxia, including VEGF, which encodes vascular endothelial growth factor, a key regulator of angiogen- esis; GLUT1, which encodes glucose transporter 1; and HK1 and HK2, which encode hexokinase, the first enzyme of the glycolytic pathway (4, 5).”
From Digoxin and other cardiac glycosides inhibit HIF-1α synthesis and block tumor growth (2008) · cites this paper as [5]
Citations
Cites
A new mathematical model for relative quantification in real-time RT-PCR
Pfaffl, M. W. (2001) · Nucleic Acids Research · doi:10.1093/nar/29.9.e45 · Cited by 34,610
Pfaffl, M. W. (2002) · Nucleic Acids Research · doi:10.1093/nar/30.9.e36 · Cited by 7,376
Targeting HIF-1 for cancer therapy
Semenza, G. L. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1187 · Cited by 6,717
Jaakkola, P., Mole, D. R., Tian, Y.-M., Wilson, M. I., Gielbert, J., Gaskell, S. J., Kriegsheim, A. V., Hebestreit, H. F., Mukherji, M., Schofield, C. J., et al. (2001) · Science · doi:10.1126/science.1059796 · Cited by 5,535
Self-citationThe tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis
Maxwell, P. H., Wiesener, M. S., Chang, G.-W., Clifford, S. C., Vaux, E. C., Cockman, M. E., Wykoff, C. C., Pugh, C. W., Maher, E. R., & Ratcliffe, P. J. (1999) · Nature · doi:10.1038/20459 · Cited by 5,180
Self-citationHIFα Targeted for VHL-Mediated Destruction by Proline Hydroxylation: Implications for O 2 Sensing
Ivan, M., Kondo, K., Yang, H., Kim, W., Valiando, J., Ohh, M., Salic, A., Asara, J. M., Lane, W. S., & Kaelin Jr., W. G. (2001) · Science · doi:10.1126/science.1059817 · Cited by 4,735
Castagna, M., Takai, Y., Kaibuchi, K., Sano, K., Kikkawa, U., & Nishizuka, Y. (1982) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)34459-4 · Cited by 4,725
Epstein, A. C. R., Gleadle, J. M., McNeill, L. A., Hewitson, K. S., O'Rourke, J., Mole, D. R., Mukherji, M., Metzen, E., Wilson, M. I., Dhanda, A., et al. (2001) · Cell · doi:10.1016/s0092-8674(01)00507-4 · Cited by 3,333
Self-citationA conserved family of prolyl-4-hydroxylases that modify HIF
Bruick, R. K., & McKnight, S. L. (2001) · Science · doi:10.1126/science.1066373 · Cited by 2,549
Oxygen sensing by HIF hydroxylases
Schofield, C. J., & Ratcliffe, P. J. (2004) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1366 · Cited by 2,068
Self-citation
Research works printed but not linked: 3
- Alarcon, 1999, Cancer Res., 59, 6046
- Sowter, 2003, Cancer Res., 63, 6130
- Charpentier, 2000, Cancer Res., 60, 5977
Cited by
Items 201–300 of 470
Weidemann, A., Breyer, J., Rehm, M., Eckardt, K., Daniel, C., Cicha, I., Giehl, K., & Goppelt‐Struebe, M. (2013) · Cell Communication and Signaling · doi:10.1186/1478-811x-11-80 · Cited by 50
MicroRNAs, Hypoxia and the Stem-Like State as Contributors to Cancer Aggressiveness
Macharia, L. W., Muriithi, W., Mureithi, M., Pereira, C. M., Ferrer, V. P., & Moura‐Neto, V. (2019) · Frontiers in Genetics · doi:10.3389/fgene.2019.00125 · Cited by 49
Molecular correlates of response to nivolumab at baseline and on treatment in patients with RCC
Ross‐Macdonald, P., Walsh, A. M., Chasalow, S. D., Ammar, R., Papillon‐Cavanagh, S., Szabó, P. M., Choueiri, T. K., Sznol, M., & Wind‐Rotolo, M. (2021) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2020-001506 · Cited by 52
“Our ‘CD3TCR’ score was highly correlated with ‘TIS’, ‘T-effector’, and ‘JAVELIN’ scores, and these four T-cell/inflammation-related scores were highest in the ccrcc4-like subtype, although CD274 (PD-L1) was their only shared transcript (online supplemental table S1).”
Prolyl hydroxylase inhibitor treatment confers whole‐animal hypoxia tolerance
Kasiganesan, H., Sridharan, V., & Wright, G. L. (2007) · Acta Physiologica · doi:10.1111/j.1748-1716.2007.01676.x · Cited by 49
“Further supporting this view, a recent report examining global changes in gene expression in response to PHI treatment found a remarkable high degree of concurrence between the changes caused by hypoxia and PHI treatment (Elvidge et al. 2006).”
BackgroundGene expression profiling to dissect the complexity of cancer biology: Pitfalls and promise
Raspé, E., Decraene, C., & Berx, G. (2012) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2012.02.011 · Cited by 51
Hypoxia-inducible factor as a bridge between healthy barrier function, wound healing, and fibrosis
Steiner, C. A., Cartwright, I. M., Taylor, C. T., & Colgan, S. P. (2022) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00227.2022 · Cited by 45
Warnecke, C., Weidemann, A., Volke, M., Schietke, R. E., Wu, X., Knaup, K. X., Hackenbeck, T., Bernhardt, W. M., Willam, C., Eckardt, K., et al. (2008) · Experimental Cell Research · doi:10.1016/j.yexcr.2008.03.003 · Cited by 55
Hypoxia-Inducible Factor 2α Plays a Critical Role in the Formation of Alveoli and Surfactant
Huang, Y., Kempen, M. B., Munck, A. B., Swagemakers, S. M. A., Driegen, S., Mahavadi, P., Meijer, D., van IJcken, W. F. J., van der Spek, P. J., Grosveld, F. G., et al. (2012) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2011-0024oc · Cited by 51
Di, K., Lomeli, N., Wood, S. D., Vanderwal, C. D., & Bota, D. A. (2016) · Oncotarget · doi:10.18632/oncotarget.12681 · Cited by 50
“While HIF-1α is involved in a plethora of pathways, only a few genes have been established as direct targets by identification of critical HIF-1α binding sites [29].”
BackgroundHulikova, A., Aveyard, N., Harris, A. L., Vaughan-Jones, R. D., & Swietach, P. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.547844 · Cited by 42
Zakharova, E. T., Kostevich, V. A., Av, S., & Vasilyev, V. B. (2012) · BioMetals · doi:10.1007/s10534-012-9586-y · Cited by 45
“Hypoxia is known to activate a number of genes coding for proteins involved in the mechanisms of iron storage and erythropoiesis, such as TF and its receptor, EPO, CP, Ft and GDF15 (Elvidge et al. 2006).”
BackgroundIL-17A and IL-17F orchestrate macrophages to promote lung cancer
Ferreira, N. L. C., Mesquita, I., Baltazar, F., Silvestre, R., & Granja, S. (2020) · Cellular Oncology · doi:10.1007/s13402-020-00510-y · Cited by 47
Wojdyła, Z., & Borowski, T. (2022) · Chemistry - A European Journal · doi:10.1002/chem.202104106 · Cited by 43
Two functional loci in the promoter of EPAS1 gene involved in high-altitude adaptation of Tibetans
Xu, X.-H., Huang, X.-W., Li, Q., Li, Y.-N., Wang, Y., Liu, C., Ma, Y., Liu, Q.-M., Sun, K., Qian, F., et al. (2014) · Scientific Reports · doi:10.1038/srep07465 · Cited by 51
FoxO Proteins Mediate Hypoxic Induction of Connective Tissue Growth Factor in Endothelial Cells
Samarin, J., Wessel, J., Cicha, I., Kroening, S., Warnecke, C., & Goppelt-Struebe, M. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.049650 · Cited by 42
Modulation of IL-1β and VEGF expression in rat diabetic retinopathy after PACAP administration
D’Amico, A. G., Maugeri, G., Rasà, D. M., Bucolo, C., Saccone, S., Federico, C., Cavallaro, S., & D’Agata, V. (2017) · Peptides · doi:10.1016/j.peptides.2017.09.014 · Cited by 43
“This latter induces the transcriptional activation of different genes, including vascular endothelial growth factors (VEGF) [15,16].”
Hyvärinen, J., Parikka, M., Sormunen, R., Rämet, M., Tryggvason, K., Kivirikko, K. I., Myllyharju, J., & Koivunen, P. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.145904 · Cited by 44
Kroening, S., Neubauer, E., Wessel, J., Wiesener, M. S., & Goppelt‐Struebe, M. (2009) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfp305 · Cited by 43
Müller, H.-D., Cvikl, B., Gruber, R., Watzek, G., & Agis, H. (2012) · Journal of Endodontics · doi:10.1016/j.joen.2012.08.003 · Cited by 42
“Physiologically, angiogenesis is governed in part by cellular oxygen sensors, including the prolyl hydroxylase domain–containing proteins (PHDs) (19, 20).”
BackgroundInfluentialCouvé, S., Ladroue, C., Laine, É., Mahtouk, K., Guégan, J., Gad, S., Jeune, H. L., Gentil, M. L., Nuel, G., Kim, W. Y., et al. (2014) · Cancer Research · doi:10.1158/0008-5472.can-14-1161 · Cited by 45
Self-citationGenome-wide mapping of Hif-1α binding sites in zebrafish
Greenald, D., Jeyakani, J., Pelster, B., Sealy, I. M., Mathavan, S., & van Eeden, F. J. (2015) · BMC Genomics · doi:10.1186/s12864-015-2169-x · Cited by 46
Hinek, A., Kim, H. J., Wang, Y., Wang, A., & Mitts, T. F. (2014) · Journal of Dermatological Science · doi:10.1016/j.jdermsci.2014.05.011 · Cited by 41
Ayrapetov, M. K., Xu, C., Sun, Y., Zhu, K., Parmar, K., D'Andrea, A. D., & Price, B. D. (2011) · PLoS ONE · doi:10.1371/journal.pone.0026064 · Cited by 41
“. One of these, dimethyloxalylglycine (DMOG), is a cell-permeable inhibitor of both proline and asparaginyl hydroxylases”
BackgroundFitzgerald, J. A., Jameson, H. M., Fowler, V. H. D., Bond, G. L., Bickley, L. K., Webster, T. M. U., Bury, N. R., Wilson, R. J., & Santos, E. M. (2016) · Environmental Science & Technology · doi:10.1021/acs.est.6b01472 · Cited by 41
Bailey, P. S. J., & Nathan, J. A. (2018) · Biomedicines · doi:10.3390/biomedicines6020060 · Cited by 41
Foti, R., Zucchelli, S., Biagioli, M., Roncaglia, P., Vilotti, S., Calligaris, R., Krmac, H., Girardini, J. E., Sal, G. D., & Gustincich, S. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.088294 · Cited by 44
Gene therapy progress and prospects: therapeutic angiogenesis for ischemic cardiovascular disease
Vincent, K. A., Jiang, C., Boltje, I., & Kelly, R. A. (2007) · Gene Therapy · doi:10.1038/sj.gt.3302953 · Cited by 42
Koperek, O., Akin, E., Asari, R., Niederle, B., & Neuhold, N. (2013) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/s00428-013-1484-3 · Cited by 40
“As shown previously, HIF-1 regulates the secretion or production of many factors that may be involved in stroma formation such as fibronectin, TGFβ, collagens and enzymes cross-linking collagen as well as metalloproteases and lysyl oxidases [11].”
BackgroundZhang, Y., Cheng, Y., Zhang, Z., Bai, Z.-Y., Jin, H., Guo, X., Huang, X., Li, M., Wang, M., Shu, X., et al. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.00725 · Cited by 44
Kroening, S., Neubauer, E., Wullich, B., Aten, J., & Goppelt‐Struebe, M. (2009) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00528.2009 · Cited by 47
Villar, D., Ortiz-Barahona, A., Gómez-Maldonado, L., Pescador, N., Sánchez-Cabo, F., Hackl, H., Rodriguez, B. A. T., Trajanoski, Z., Dopazo, A., Huang, T. H. M., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0045708 · Cited by 36
Hypoxia represses microRNA biogenesis proteins in breast cancer cells
Bandara, V., Michael, M., & Gleadle, J. (2014) · BMC Cancer · doi:10.1186/1471-2407-14-533 · Cited by 42
Self-citationMultiple renal cancer susceptibility polymorphisms modulate the HIF pathway
Grampp, S., Schmid, V., Salama, R. A., Lauer, V., Kranz, F., Platt, J. L., Smythies, J., Choudhry, H., Goppelt‐Struebe, M., Ratcliffe, P. J., et al. (2017) · PLoS Genetics · doi:10.1371/journal.pgen.1006872 · Cited by 40
Self-citationHarvey, A. J., Kind, K. L., & Thompson, J. G. (2007) · Biology of Reproduction · doi:10.1095/biolreprod.106.058826 · Cited by 42
Frietze, S. E., O’Geen, H., Littlepage, L. E., Simion, C., Sweeney, C. A., Farnham, P., & Krig, S. R. (2014) · BMC Genomics · doi:10.1186/1471-2164-15-520 · Cited by 38
“…to side population (SP) MCF7 cells positive for MUC1 (Engelmann [30]), (e) Genes up-regulated in MCF-7 cells under hypoxia and (Elvidge [31]), (f) Genes that change according to the ESR1 status: ER positive vs ER negative tumor (Doane [32]), and (g) Genes up-regulated in MCF7 cells…”
Huang, Y., Ochieng, J. K., Kempen, M. B., Munck, A. B., Swagemakers, S. M. A., van IJcken, W. F. J., Grosveld, F. G., Tibboel, D., & Rottier, R. J. (2013) · PLoS ONE · doi:10.1371/journal.pone.0057695 · Cited by 48
Jordanovski, D., Herwartz, C., Pawlowski, A. E., Taute, S., Frommolt, P., & Steger, G. (2013) · PLoS ONE · doi:10.1371/journal.pone.0074911 · Cited by 40
“As already mentioned, data from the literature suggested that ZNF395 is a hypoxia-induced gene [9,41].”
BackgroundDu, J., Liu, L., Lay, F., Wang, Q., Dou, C.-X., Zhang, X., Hosseini, S. M., Simon, A., Rees, D. J., Ahmed, A. K., et al. (2013) · Gene Therapy · doi:10.1038/gt.2013.32 · Cited by 37
Sardo, U., Perrier, P., Cormier, K., Sotin, M., Personnaz, J., Medjbeur, T., Desquesnes, A., Cannizzo, L., Ruíz-Martínez, M., Thevenin, J., et al. (2024) · Blood · doi:10.1182/blood.2023022724 · Cited by 41
Chronic hypoxia leads to a glycolytic phenotype and suppressed HIF-2 signaling in PC12 cells
Zhdanov, A. V., Dmitriev, R. I., Golubeva, A. V., Gavrilova, S. A., & Papkovsky, D. B. (2013) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2013.02.016 · Cited by 37
Al-Greene, N. T., Means, A. L., Wang, L., Jiang, A., Schmidt, C. R., Chakravarthy, A. B., Merchant, N. B., Washington, M. K., Zhang, B., Shyr, Y., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0069660 · Cited by 37
Meade, E., Ma, Y., & Guller, S. M. (2007) · Placenta · doi:10.1016/j.placenta.2007.04.005 · Cited by 41
“Several studies suggest that relative contributions of HIF-1α and HIF-2α in hypoxia-mediated changes in gene expression are both cell type- and gene-specific [26-28,41].”
BackgroundEffect of TET inhibitor on bovine parthenogenetic embryo development
Zhang, J., Zhang, S., Wang, Y., Cheng, H., Hao, L., Zhai, Y., Zhang, Z., An, X., Ma, X., Zhang, X., et al. (2017) · PLoS ONE · doi:10.1371/journal.pone.0189542 · Cited by 40
Zhao, B., Liu, L., Mao, J., Zhang, Z., Wang, Q., & Li, Q. (2021) · Cell Death and Disease · doi:10.1038/s41419-021-03387-3 · Cited by 36
Hypoxia as a target for drug combination therapy of liver cancer
Bowyer, C. J., Lewis, A. L., Lloyd, A. W., Phillips, G. J., & Macfarlane, W. M. (2017) · Anti-Cancer Drugs · doi:10.1097/cad.0000000000000516 · Cited by 36
Choline phosphorylation and regulation of transcription of choline kinase α in hypoxia
Bansal, A., Harris, R. A., & DeGrado, T. R. (2011) · Journal of Lipid Research · doi:10.1194/jlr.m021030 · Cited by 35
Ghazoui, Z. F., Buffa, F. M., Dunbier, A. K., Anderson, H., Dexter, T., DETRE, S. I., Salter, J., Smith, I. E., Harris, A. L., & Dowsett, M. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-1704 · Cited by 36
Page, S., Raut, S., & Al-Ahmad, A. J. (2019) · NeuroMolecular Medicine · doi:10.1007/s12017-019-08531-z · Cited by 38
Brewitz, L., Tumber, A., & Schofield, C. J. (2020) · Journal of Biological Chemistry · doi:10.1074/jbc.ra119.012202 · Cited by 34
Brewitz, L., Tumber, A., Pfeffer, I., McDonough, M. A., & Schofield, C. J. (2020) · Scientific Reports · doi:10.1038/s41598-020-65123-9 · Cited by 34
Hypoxic microenvironment shapes HIV-1 replication and latency
Zhuang, X., Pedroza‐Pacheco, I., Nawroth, I., Kliszczak, A. E., Magri, A., Paes, W., Rubio, C. O., Yang, H., Ashcroft, M. A., Mole, D. R., et al. (2020) · Communications Biology · doi:10.1038/s42003-020-1103-1 · Cited by 35
Hussain, K., Liu, R., Smith, R. C. G., Müller, K. T. J., Ghorbani, M., Macari, S. A., Cleary, K. L. S., Oldham, R. J., Foxall, R. B., James, S., et al. (2022) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-022-02294-5 · Cited by 36
“We utilized DMOG for its previously reported ability to activate HIFs and induce downstream gene expression patterns that show concordance with those observed under physiological hypoxia [80].”
MethodPoitz, D. M., Augstein, A., Hesse, K., Christoph, M., Ibrahim, K. S., Braun-Dullaeus, R. C., Strasser, R. H., & Schmeißer, A. (2013) · Molecular Immunology · doi:10.1016/j.molimm.2013.10.001 · Cited by 35
c-MYC inhibition impairs hypoxia response in glioblastoma multiforme
Mongiardi, M. P., Savino, M., Falchetti, M. L., Illi, B., Bozzo, F., Valle, C., Helmer‐Citterich, M., Ferrè, F., Nasi, S., & Levi, A. (2016) · Oncotarget · doi:10.18632/oncotarget.8921 · Cited by 35
“As shown in Figure 1C gene sets identified upon exposure to hypoxia [19] [20], hypoxia-mimetic drugs, upregulation of HIF1A or its depletion by RNA interference [21] were significantly enriched in hypoxic U87FO cells.”
BackgroundTET protein inhibitors: Potential and limitations
Kaplánek, R., Kejík, Z., Hajduch, J., Veselá, K., Kučnirová, K., Skaličková, M., Venhauerova, A., Hosnedlová, B., Hromádka, R., Dytrych, P., et al. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.115324 · Cited by 38
Pant, D., Narayanan, S. P., Vijay, N., & Shukla, S. (2020) · Journal of Biosciences · doi:10.1007/s12038-019-9977-0 · Cited by 35
Deep topographic proteomics of a human brain tumour
Davis, S. A., Scott, C., Oetjen, J., Charles, P. D., Kessler, B. M., Ansorge, O., & Fischer, R. (2023) · Nature Communications · doi:10.1038/s41467-023-43520-8 · Cited by 33
“Aspartate beta-hydroxylase (ASPH) shows highest intensity in those voxels furthest away from blood vessels, consistent with observations that ASPH can be regulated by hypoxia 46,47 .”
Nakajima, A., Endo, H., Okuyama, H., Kiyohara, Y., Kimura, T., Kamiura, S., Hiraoka, M., & Inoue, M. (2014) · International Journal of Cancer · doi:10.1002/ijc.29349 · Cited by 34
Defining hypoxia in cancer: A landmark evaluation of hypoxia gene expression signatures
Giovannantonio, M. D., Hartley, F., Elshenawy, B., Barberis, A., Hudson, D., Shafique, H. S., Allott, V. E. S., Harris, D. A., Lord, S., Haider, S., et al. (2025) · Cell Genomics · doi:10.1016/j.xgen.2025.100764 · Cited by 38
Travelling under pressure - hypoxia and shear stress in the metastatic journey
Ildız, E. S., Gvozdenovic, A., Kovacs, W. J., & Aceto, N. (2023) · Clinical & Experimental Metastasis · doi:10.1007/s10585-023-10224-8 · Cited by 39
Follistatin-like protein 1 plays a tumor suppressor role in clear-cell renal cell carcinoma
Liu, Y., Tan, X., Liu, W., Chen, X., Hou, X., Shen, D., Ding, Y., Yin, J., Wang, L., Zhang, H., et al. (2018) · 癌症:英文版 · doi:10.1186/s40880-018-0267-2 · Cited by 31
“The representative gene sets with the highest NES score in the NF-κB- and the HIF-related signaling subnetworks were named “Hinata NF-κB targets keratinocyte up” [35] and “Elvidge HIF1α and HIF2α targets up” [36], respectively (Fig.”
MethodSaber, S., Abdelhady, R., Elhemely, M. A., Elmorsy, E. A., Hamad, R. S., Abdel‐Reheim, M. A., El-kott, A. F., AlShehri, M. A., Morsy, K., Negm, S., et al. (2024) · International Journal of Nanomedicine · doi:10.2147/ijn.s497041 · Cited by 32
Rodríguez-Pérez, J., Andreu-Martínez, R., Daza, R., Fernández-Arroyo, L., Hernández-García, A., Díaz‐García, E., Cubillos‐Zapata, C., Lozano-Díez, A., Morales, A., Ramos, D., et al. (2025) · Antioxidants · doi:10.3390/antiox14070839 · Cited by 38
“The central role of HIFs in hypoxia is further reinforced by early studies showing that most hypoxia-induced genes are dependent on HIF activity [50].”
Chen, X., Gao, H. Y., Han, Y., Ye, J., Xie, J., & Wang, C. (2015) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2015.07.008 · Cited by 30
RetractedPierre, C. C., Longo, J., Bassey-Archibong, B. I., Hallett, R. M., Milosavljevic, S., Beatty, L., Hassell, J. A., & Daniel, J. M. (2015) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2015.10.018 · Cited by 32
Sheffer, M., Simon, A. J., Jacob‐Hirsch, J., Rechavi, G., Domany, E., Givol, D., & D’Orazi, G. (2011) · Oncotarget · doi:10.18632/oncotarget.395 · Cited by 30
“A large overlap with hypoxia related genes compiled by MSigDB database [19] on the basis of ten different studies [20-29] supported the hypoxia-like effect of cobalt.”
BackgroundMethodAmbrose, L. J. A., Jamil, A. H. A., Gomes, R. S. M., Carter, E. E., Carr, C. A., Clarke, K., & Heather, L. C. (2014) · Journal of Cardiovascular Pharmacology and Therapeutics · doi:10.1177/1074248414524480 · Cited by 34
McGillick, E. V., Orgeig, S., & Morrison, J. L. (2016) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00469.2015 · Cited by 33
Differential contribution of key metabolic substrates and cellular oxygen in HIF signalling
Zhdanov, A. V., Waters, A. H. C., Golubeva, A. V., & Papkovsky, D. B. (2014) · Experimental Cell Research · doi:10.1016/j.yexcr.2014.10.005 · Cited by 31
Perrotta, S., Stiehl, D. P., Punzo, F., Scianguetta, S., Borriello, A., Bencivenga, D., Casale, M., Nobili, B., Fasoli, S., Balduzzi, A., et al. (2013) · Haematologica · doi:10.3324/haematol.2013.088369 · Cited by 33
Ensemble analyses improve signatures of tumour hypoxia and reveal inter-platform differences
Fox, N. S., Starmans, M. H. W., Haider, S., Lambin, P., & Boutros, P. C. (2014) · BMC Bioinformatics · doi:10.1186/1471-2105-15-170 · Cited by 32
“The following signatures were included: Buffa metagene [13], Chi signature [14], Elvidge up gene set [15], Hu signature [16], the 0% and 2% early Seigneuric signatures [17], Sorensen gene set [18], Winter metagene [19] and Starmans clusters 1 to 7 [20].”
In vitro downregulated hypoxia transcriptome is associated with poor prognosis in breast cancer
Abu‐Jamous, B., Buffa, F. M., Harris, A. L., & Nandi, A. K. (2017) · Molecular Cancer · doi:10.1186/s12943-017-0673-0 · Cited by 32
“D06 GSE3188 2005 GPL96 Affymetrix HG-U133A 3 MCF7 Samples at normoxia, hypoxia, and normoxia exposed to DMOG, respectively [67]”
MethodMayorga, M. E., Kiedrowski, M. J., Shamhart, P. E., Forudi, F., Weber, K., Chilian, W. M., Penn, M. S., & Dong, F. (2015) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00449.2015 · Cited by 29
“DMOG is a prolyl-4-hydroxylase inhibitor, which stabilizes HIF-1 by inhibiting HIF-1 hydroxylases, thereby preventing degradation (10, 25).”
BackgroundPFKFB4 interacts with FBXO28 to promote HIF-1α signaling in glioblastoma
Phillips, E. S., Balß, J., Bethke, F., Pusch, S., Christen, S., Hielscher, T., Schnölzer, M., Fletcher, M. N. C., Habel, A., Tessmer, C., et al. (2022) · Oncogenesis · doi:10.1038/s41389-022-00433-3 · Cited by 28
“[27], Elvidge) to the gene expression list of PFKFB4-silenced GSCs in a rank order based on the mean linear fold change of the genes.”
BackgroundYan, H., Zhang, D., Shi, X., Zhang, Q., & Huang, Y. (2012) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2011.01500.x · Cited by 30
“More importantly, activation of the PHD signal pathway via PHD inhibitor (PHI) mediates a variety of cellular responses to hypoxia and preconditioning stimuli [6].”
BackgroundBerezowska, S., Galván, J. A., Langer, R., Bubendorf, L., Savic, S., Gugger, M., Schmid, R. A., & Marti, T. M. (2017) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/s00428-016-2057-z · Cited by 32
“Since hypoxia-induced stabilization of HIF-1 α is reversible under normoxic conditions within minutes, we treated A549 cells with the prolylhydroxylase inhibitor DMOG, which chemically mimics hypoxia and stabilizes HIF-1 α under normoxic conditions [18, 19].”
Thorn, C. C., Freeman, T. C., Scott, N., Guillou, P. J., & Jayne, D. G. (2008) · Gut · doi:10.1136/gut.2008.157255 · Cited by 27
The Transcription Factor Hif-1 Enhances the Radio-Resistance of Mouse MSCs
Calvo‐Asensio, I., Dillon, E., Lowndes, N. F., & Ceredig, R. (2018) · Frontiers in Physiology · doi:10.3389/fphys.2018.00439 · Cited by 28
“done using different approaches ranging from genome-wide transcript profiling using expression micro-arrays to more recent chromatin immunoprecipitation coupled to high-throughput sequencing (ChIP-Seq) techniques (Hu et al., 2003; Greijer et al., 2005; Elvidge et al., 2006; Warnecke et al., 2008; Mole et al., 2009; Xi…”
MethodComplex role of the HIF system in cardiovascular biology
Czibik, G. (2010) · Journal of Molecular Medicine · doi:10.1007/s00109-010-0646-x · Cited by 32
Hypoxia-induced phase separation of ZHX2 alters chromatin looping to drive cancer metastasis
Gao, C., Gao, A., Jiang, Y., Gao, R., Guo, Y., Peng, Z., Jiang, W., Zhang, M., Zhou, Z., Yan, C., et al. (2025) · Molecular Cell · doi:10.1016/j.molcel.2025.03.009 · Cited by 29
Role of hypoxia during nephrogenesis
Hemker, S. L., Sims‐Lucas, S., & Ho, J. (2016) · Pediatric Nephrology · doi:10.1007/s00467-016-3333-5 · Cited by 27
Brewitz, L., Nakashima, Y., & Schofield, C. J. (2020) · Chemical Science · doi:10.1039/d0sc04301j · Cited by 26
Manganese-mediated acceleration of age-related hearing loss in mice
Ohgami, N., Yajima, I., Iida, M., Li, X., Oshino, R., Kumasaka, M. Y., & Kato, M. (2016) · Scientific Reports · doi:10.1038/srep36306 · Cited by 26
Fujino, T., Murakami, K., Ozawa, I., Minegishi, Y., Kashimura, R., Akita, T., Saitou, S., Atsumi, T., Sato, T., Ando, K., et al. (2009) · FEBS Journal · doi:10.1111/j.1742-4658.2009.06867.x · Cited by 27
The genotypic and phenotypic impact of hypoxia microenvironment on glioblastoma cell lines
Macharia, L. W., Muriithi, W., Heming, C. P., Nyaga, D. K., Aran, V., Mureithi, M., Ferrer, V. P., Pane, A., Filho, P. N., & Moura‐Neto, V. (2021) · BMC Cancer · doi:10.1186/s12885-021-08978-z · Cited by 25
Pu, R., Liu, W., Zhou, X., 侯晓玫, Cai, S., Chen, X., Chen, L., Wu, J., Yang, F., Tan, X., et al. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.836517 · Cited by 27
Jiang, W., Zhang, M., Gao, C., Yan, C., Gao, R., He, Z., Wei, X. L., Xiong, J., Ruan, Z.-L., Yang, Q., et al. (2023) · The EMBO Journal · doi:10.15252/embj.2023113743 · Cited by 26
Herwartz, C., Castillo-Juárez, P., Schröder, L., Barrón, B. L., & Steger, G. (2015) · Mediators of Inflammation · doi:10.1155/2015/804264 · Cited by 25
Gene expression module-based chemical function similarity search
Li, Y., Hao, P., Zheng, S., Tu, K., Fan, H., Zhu, R., Ding, G., Wang, C., Wang, C., Li, X., et al. (2008) · Nucleic Acids Research · doi:10.1093/nar/gkn610 · Cited by 26
Uncovering the role of LINE-1 in the evolution of lung adenocarcinoma
Zhang, T., Wei, Z., Wirth, C., Díaz‐Gay, M., Yin, J., Cecati, M., Marchegiani, F., Hoang, P. H., Leduc, C., Baine, M. K., et al. (2025) · Nature · doi:10.1038/s41586-025-09825-y · Cited by 25
Zhang, D., An, X., Li, Z., & Zhang, S. (2019) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2019.7481 · Cited by 25
“DMOG is a non‑specific 2‑OG‑dependent dioxygenase inhibitor (37).”
Fagundes, R. R., Bourgonje, A. R., Hu, S., Barbieri, R., Jansen, B. H., Sinnema, N., Blokzijl, T., Taylor, C. T., Weersma, R. K., Faber, K. N., et al. (2022) · Frontiers in Physiology · doi:10.3389/fphys.2022.889091 · Cited by 24
Baek, J. H., Reiter, C. E. N., Manalo, D. J., Buehler, P. W., Hider, R. C., & Alayash, A. I. (2011) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2011.04.010 · Cited by 25
Takahashi, E., & Sato, M. (2013) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00255.2013 · Cited by 25
Simpson, P. D., Eipper, B. A., Katz, M. J., Gándara, L., Wappner, P., Fischer, R., Hodson, E. J., Ratcliffe, P. J., & Masson, N. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.667246 · Cited by 27
Self-citationImpaired Organization of GABAergic Neurons Following Prenatal Hypoxia
Nisimov, H., Orenbuch, A., Pleasure, S. J., & Golan, H. M. (2018) · Neuroscience · doi:10.1016/j.neuroscience.2018.05.021 · Cited by 24
García-Aguilar, A., Martínez‐Reyes, I., & Cuezva, J. M. (2019) · Journal of Proteome Research · doi:10.1021/acs.jproteome.9b00239 · Cited by 25
Semenza, G. L. (2008) · Cell · doi:10.1016/j.cell.2008.04.004 · Cited by 24
“Database searches led to the identification of HIF-2α, which is also regulated by O2, dimerizes with HIF-1β, and regulates an overlapping but distinct battery of target genes (Elvidge et al., 2006; Patel and Simon, 2008).”
BackgroundInhibition of Rho kinases increases directional motility of microvascular endothelial cells
Breyer, J., Samarin, J., Rehm, M., Lautscham, L. A., Fabry, B., & Goppelt‐Struebe, M. (2011) · Biochemical Pharmacology · doi:10.1016/j.bcp.2011.12.012 · Cited by 27
Tiana, M., Acosta-Iborra, B., Hernández, R., Galiana, C., Fernández-Moreno, M. Á., Jimenez, B., & del Peso, L. (2020) · RNA · doi:10.1261/rna.072611.119 · Cited by 23
“Furthermore, HIF1A and EPAS1 present two transactivation domains NTAD and CTAD that can bind transcriptional co-regulators such as CBP/p300 and the cyclin dependent kinase 8 (CDK8) (Galbraith et al. 2013; Arany et al. 1996; Kasper et al. 2005; Dengler et al. 2014; Choudhry et al. 2014).”
Background
Metadata
- Authors
- Elvidge, G. P., Glenny, L., Appelhoff, R. J., Ratcliffe, P. J., Ragoussis, J., & Gleadle, J. M.
- Affiliations
- University of Oxford (GB)
- Centre for Human Genetics (GB)
- Corresponding author
- Ragoussis, Jiannis
- Gleadle, Jonathan M.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2006-06
- Volume
- 281
- Issue
- 22
- Pages
- 15215-15226
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2011076742
- Cited by
- 464
- References
- 58
- Citations by year
- 2026: 13 · 2025: 13 · 2024: 18 · 2023: 15 · 2022: 25 · 2021: 20 · 2020: 33 · 2019: 16 · 2018: 20 · 2017: 21 · 2016: 19 · 2015: 28 · 2014: 34 · 2013: 35 · 2012: 27
- FWCI
- 10.83
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- creativecommons.org/licenses/by/4.0/ (vor, 5221 d)
- Locations
- Journal of Biological Chemistry (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- Wellcome Trust
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Health Sciences › Medicine › Hematology › Erythropoietin and Anemia Treatment
- Physical Sciences › Chemistry › Inorganic Chemistry › Metal-Catalyzed Oxygenation Mechanisms
- Keywords
- hypoxia, 2-oxoglutarate-dependent dioxygenase, dimethyloxalylglycine, hypoxia-inducible factor, HIF-1α, HIF-2α, oxygen sensing, gene expression regulation, prolyl hydroxylation, PHD1, PHD2, PHD3, FIH-1, MCF-7 cells
- MeSH terms
- Endothelial PAS Domain-Containing Protein 1, Amino Acids, Dicarboxylic, Cell Line, Enzyme Inhibitors, Gene Expression Regulation, Humans, Ketoglutarate Dehydrogenase Complex, RNA, Messenger, Transcription Factors, Cell Hypoxia, Oligonucleotide Array Sequence Analysis, Gene Expression Profiling, RNA, Small Interfering, Basic Helix-Loop-Helix Proteins, Hypoxia-Inducible Factor 1, alpha Subunit
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.